Literature DB >> 21548457

Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept.

N Cancelliere1, P Barranco, C Vidaurrázaga, D-M Benito, S Quirce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21548457

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  4 in total

Review 1.  Hypereosinophilia and seroconversion of rheumatoid arthritis.

Authors:  Rachel K Rosenstein; Richard S Panush; Neil Kramer; Elliot D Rosenstein
Journal:  Clin Rheumatol       Date:  2014-03-08       Impact factor: 2.980

2.  Development of peripheral eosinophilia in inflammatory bowel disease patients on infliximab treated at a tertiary pediatric inflammatory bowel disease center is associated with clinically active disease but does not result in loss of efficacy or adverse outcomes.

Authors:  Douglas Zabrowski; Danielle Abraham; Geoffrey Rosenthal; Howard Kader
Journal:  JGH Open       Date:  2020-02-07

3.  Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis.

Authors:  Naoto Azuma; Kiyoshi Matsui; Naoaki Hashimoto; Takahiro Yoshikawa; Hajime Sano
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

4.  Loeffler Endocarditis: A Unique Presentation of Right-Sided Heart Failure Due to Eosinophil-Induced Endomyocardial Fibrosis.

Authors:  Amit Alam; Shankar Thampi; Shahryar G Saba; Rita Jermyn
Journal:  Clin Med Insights Case Rep       Date:  2017-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.